NSE: BALRAMCHIN · 2 November 2026
- Balrampur Chini Mills Ltd. (BALRAMCHIN) advanced by 1.76% today, settling at ₹599.90 after moving within a daily range of ₹580.70 and ₹601.20.
- Balrampur Chini Mills received ₹75 crore in grant assistance from the Biotechnology Industry Research Assistance Council (BIRAC) under the Department of Biotechnology to establish a 100 TPA PLA Co-Polymer R&D facility in Kumbhi, Uttar Pradesh. The pilot-scale facility will accelerate development of advanced bio-based materials and support the company's broader biomanufacturing strategy. This initiative aims to bridge laboratory research and commercial-scale manufacturing for sustainable biopolymers.
- Trading volume was 1.08 times the 20-day average daily volume.
Why is Balrampur Chini Mills share price rising on 2 November 2026?
Balrampur Chini Mills Ltd. (BALRAMCHIN) advanced by 1.76% today, settling at ₹599.90 after moving within a daily range of ₹580.70 and ₹601.20.
The broader market and sectoral trend provided supportive backdrop during the session, as the Nifty benchmark rose 1.68% and the Nifty FMCG sector index gained 0.84%. Despite today's positive price action, the stock has experienced recent downward pressure, registering a 4.41% decline over the preceding 5 trading days and a 7.90% drop over the past 20 trading days.
While the company recently received a ₹75 crore BioE3 grant from the Department of Biotechnology and BIRAC to establish a pilot-scale PLA Co-Polymer R&D facility in Uttar Pradesh, there is no direct evidence explicitly linking this announcement to today's share price movement. Investor attention remains focused on upcoming financial disclosures and scheduled analyst interactions.
11.08 lakh shares traded by 2 November 2026 · 03:30 PM IST. This compares with a 20-day average daily volume of 10.23 lakh shares (1.08 times). The five-day average daily volume was 5.23 lakh shares. Separately, the NSE report for 2 November 2026 showed 5.13 lakh shares delivered, representing 46.26% of that day’s traded volume. The same report recorded 41,939 trades.
The stock recovered 1.76% on above-average volume after recording consecutive declines in prior sessions (-7.19% and -6.90%), with no single confirmed corporate catalyst driving today's specific move.
Latest Company Developments
Balrampur Chini Mills received ₹75 crore in grant assistance from the Biotechnology Industry Research Assistance Council (BIRAC) under the Department of Biotechnology to establish a 100 TPA PLA Co-Polymer R&D facility in Kumbhi, Uttar Pradesh. The pilot-scale facility will accelerate development of advanced bio-based materials and support the company's broader biomanufacturing strategy. This initiative aims to bridge laboratory research and commercial-scale manufacturing for sustainable biopolymers.
It strengthens the company's long-term strategic positioning in the green chemistry and bioplastics sector, though it serves as background context rather than an immediate catalyst for today's trading session.
The company held its 50th Annual General Meeting through video conferencing where shareholders adopted standalone and financial statements and approved the final dividend of ₹3.50 per share for the financial year ended March 31, 2026. Members also approved the re-appointment of Vivek Saraogi as Chairman and Managing Director and Avantika Saraogi as Executive Director for five-year terms starting in 2027.
Provides continuity in executive leadership and formalizes shareholder returns, though routine governance updates do not directly dictate daily price fluctuations.
Balrampur Chini Mills Limited has informed that the Executive Committee of the Board of Directors of the Company have approved the allotment of 44287 equity shares of Re 1/- each of the Company, fully paid up, at their meeting held today, i.e., 24th October, 2026, to the employees of the Company pursuant to exercise of Employees Stock Appreciation Rights, as per BCML Employees Stock Appreciation Rights Plan 2023.
'Reminder intimation sent to the Physical Shareholders to update KYC details and Claim Unpaid/Unclaimed Dividends and Shares'.
'Letter To The Members Pursuant To Regulation 36(1)(B) Of SEBI (LODR) Regulations, 2015'.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 27.55% on 30 September 2026. This compares with 25.83% on 30 June 2026, a change of +1.72 percentage points.
The filing reported 29 MF/UTI holders.
Research & Brokerage Views
Historical Bulk / Block Deals
What to Watch Next
- Upcoming announcement of unaudited financial results and interim dividend consideration
- Management commentary during the scheduled analyst and investor conference call
- Execution progress on the upcoming commercial PLA manufacturing and R&D facilities
- Sustained delivery percentage and volume trends against the 20-day average volume baseline
More Balrampur Chini Mills news and dated analysis →
Frequently Asked Questions
What is the latest Balrampur Chini Mills company news?
Balrampur Chini Mills received ₹75 crore in grant assistance from the Biotechnology Industry Research Assistance Council (BIRAC) under the Department of Biotechnology to establish a 100 TPA PLA Co-Polymer R&D facility in Kumbhi, Uttar Pradesh. The pilot-scale facility will accelerate development of advanced bio-based materials and support the company's broader biomanufacturing strategy. This initiative aims to bridge laboratory research and commercial-scale manufacturing for sustainable biopolymers.
How strong was Balrampur Chini Mills’s trading volume?
11.08 lakh shares traded, 1.08 times the 20-day average daily volume. The price and volume data are dated 2 November 2026 · 03:30 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.